The CHPT1 gene helps your cells make phosphatidylcholine, a major fat that forms healthy cell membranes. If the CHPT1 gene does not work properly, cells may struggle to build and maintain these membranes, which can especially affect the brain and nerves. Some people with disease-causing variants in both copies of the CHPT1 gene have developmental delay, muscle weakness, stiffness, or problems with movement and balance. This is not a widely known public interest gene, but it is important in rare inherited neurologic conditions.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for building proteins, which do much of the cell’s work. Others mainly guide when certain activities happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a closer look at this topic, you can learn more in the LearnHub.
Overview
CHPT1Gene function
What if the gene works
The CHPT1 gene helps cells make phosphatidylcholine, a major fatty building block of cell membranes. This supports membrane structure and everyday cell signaling.
Risk
What if the gene does not work
Biallelic variants in the CHPT1 gene can cause a rare inherited nerve and muscle condition with early weakness and wasting, often in the feet and lower legs. Milder and more severe variants may influence when movement problems begin and how much stiffness develops.
Treatment
What does that mean for your treatment
For people with a pathogenic variant in the CHPT1 gene, no CHPT1-specific treatment or drug selection approach is currently established. Care is guided by the person’s symptoms and clinical needs rather than the CHPT1 result itself.
Gene function
What if the gene works
Your cells need a steady supply of membrane fats to keep their outer layer and inner compartments working smoothly. The CHPT1 gene helps make one of the most important of these fats, called phosphatidylcholine. This is a key part of how the CHPT1 gene supports healthy cell membrane function across the body.
Inside your cells, the CHPT1 gene helps carry out the last step in making phosphatidylcholine. It joins smaller pieces into a finished membrane fat that cells use every day.
Phosphatidylcholine made with help from the CHPT1 gene becomes part of cell membranes and the membranes around internal cell spaces. This supports the balance of stability and flexibility that healthy membranes need.
Cells regularly replace parts of their membranes during normal growth and upkeep. By helping replenish phosphatidylcholine, the CHPT1 gene supports this steady cycle of membrane maintenance.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply reflect natural genetic variation. In some situations, though, a variant can more substantially change how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CHPT1 gene can change the enzyme’s shape, stability, or location inside the cell, which may lower the final step of making phosphatidylcholine, a major fat in cell membranes. Milder variants may leave some activity, while more disruptive variants can greatly reduce or stop this transfer step, altering membrane composition and lipid handling. This effect of CHPT1 gene variants on cell membrane fat production can, in established CHPT1-related neurologic disease, track with how early and strongly features appear.
How variants are linked to conditions
The CHPT1 gene does not yet have a broadly confirmed link to a specific health condition, and research on CHPT1 gene variants and health conditions is still developing. If you have a confirmed CHPT1-related diagnosis, your doctor or genetic counselor can explain what that result means for you more clearly than general information can.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely seen in the general population. Most do not directly affect health and simply contribute to normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, a single well understood variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CHPT1 gene. For many living with CHPT1-related changes, risk is mainly shaped by the exact gene change inherited rather than by lifestyle or common environmental factors, and personal concerns are best discussed with a doctor or genetic counselor.
Inheritance of CHPT1 variants
CHPT1-related conditions are inherited in an autosomal recessive pattern. In practical terms, this means a child usually inherits one altered copy of the CHPT1 gene from each parent, while parents with one altered copy are typically carriers. When both parents are carriers, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy. For families trying to understand how CHPT1 gene variants are inherited, this pattern means the condition can appear in a child even when neither parent has symptoms.
What does my CHPT1 result mean for my family?
For CHPT1-related conditions, the family pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also have the condition or be carriers, even if they seem well. Other relatives, such as adult siblings or cousins planning children, may also want to learn whether they carry the family’s CHPT1 change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the CHPT1 gene, clinicians use genetic testing for CHPT1 variants, usually from a blood sample or saliva. A lab reads your DNA sequence and compares it with a reference sequence to look for variants. Results may show a variant linked to disease, a harmless variant, or an uncertain finding.
When should I consider getting a genetic test?
Testing may be worth discussing if a child has unexplained developmental delay with muscle stiffness or weakness, trouble walking, hearing loss, or brain changes on scans, especially if similar problems run in the family. CHPT1 changes are a rare cause, so doctors often look for them as part of a broader test for nerve, muscle, or developmental conditions.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies based on the condition and the kind of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down or move a drug through the body differently, so the same dose may work better for one person, have less effect in another, or cause more side effects. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics explores how differences in genes can affect the way a person responds to medications. It examines connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can help guide treatment decisions that are more informed and more personalized. More detail on this topic is available in the LearnHub.
Drugs influenced by the CHPT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so any concerns about medications, side effects, or your overall health are best discussed with your doctor.
History
CHPT1 entered the scientific literature through studies of cell membrane fats, when researchers first identified choline phosphotransferase activity before the exact gene was fully characterized. As medical science evolved, so did understanding of this gene. Later work placed CHPT1 on chromosome 12 and clarified its role within a broader family of genes involved in phospholipid production. In the 2010s, genetic studies linked rare inherited CHPT1 variants to a condition affecting movement and development, which gave the gene clearer clinical relevance. Since then, reports from affected families and improved DNA sequencing have helped refine how clinicians recognize CHPT1 related disease.